E-ISSN 2305-1620 | ISSN 2221-0288
 

Commentary

Online Publishing Date:
11 / 12 / 2023

 


Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies

Hamid Shabbir, Muhammad Babar Imran, Nayyar Rubab.


Abstract
Prostate cancer (PCa) is the 2nd most common malignancy in males and the leading cause of cancer-related deaths among men. In recent years, novel therapies have emerged for metastatic castration-resistant prostate cancer (mCRPC) including immunotherapy, androgen-receptor signaling inhibitors, and radio-nuclide therapies. DNA Damage Repair (DDR) genes are frequently mutated in advance PCa and are useful biomarkers for targeted therapy such as poly-ADP ribose polymerase (PARP) inhibitors. DDR gene defects may affect tissue radio-sensitivity and could serve as biomarkers for therapy with alpha and beta-emitting radionuclides. Preliminary clinical reports suggest a potential trend toward longer survival in DDR+ subjects when treated with α-emitters, however, survival benefit was not significant in patients treated with β-emitting radionuclides. A comprehensive study regarding the impact of DDR genes in prostate cancer patients treated with alpha emitters is vital.

Key words: Prostate Cancer, Radionuclide, Genomics, Therapy, DDR.


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Hamid Shabbir
Articles by Muhammad Babar Imran
Articles by Nayyar Rubab
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Shabbir H, Imran MB, Rubab N. Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. Pak J Nucl Med. 2023; 13(1): 13-16. doi:10.24911/PJNMed.175-1696399353


Web Style

Shabbir H, Imran MB, Rubab N. Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. https://www.pjnmed.com/?mno=171966 [Access: February 27, 2024]. doi:10.24911/PJNMed.175-1696399353


AMA (American Medical Association) Style

Shabbir H, Imran MB, Rubab N. Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. Pak J Nucl Med. 2023; 13(1): 13-16. doi:10.24911/PJNMed.175-1696399353



Vancouver/ICMJE Style

Shabbir H, Imran MB, Rubab N. Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. Pak J Nucl Med. (2023), [cited February 27, 2024]; 13(1): 13-16. doi:10.24911/PJNMed.175-1696399353



Harvard Style

Shabbir, H., Imran, . M. B. & Rubab, . N. (2023) Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. Pak J Nucl Med, 13 (1), 13-16. doi:10.24911/PJNMed.175-1696399353



Turabian Style

Shabbir, Hamid, Muhammad Babar Imran, and Nayyar Rubab. 2023. Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. Pakistan Journal of Nuclear Medicine, 13 (1), 13-16. doi:10.24911/PJNMed.175-1696399353



Chicago Style

Shabbir, Hamid, Muhammad Babar Imran, and Nayyar Rubab. "Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies." Pakistan Journal of Nuclear Medicine 13 (2023), 13-16. doi:10.24911/PJNMed.175-1696399353



MLA (The Modern Language Association) Style

Shabbir, Hamid, Muhammad Babar Imran, and Nayyar Rubab. "Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies." Pakistan Journal of Nuclear Medicine 13.1 (2023), 13-16. Print. doi:10.24911/PJNMed.175-1696399353



APA (American Psychological Association) Style

Shabbir, H., Imran, . M. B. & Rubab, . N. (2023) Genetic Perspectives on Prostate Cancer: Unveiling the Impact on Targeted Radionuclide Therapies. Pakistan Journal of Nuclear Medicine, 13 (1), 13-16. doi:10.24911/PJNMed.175-1696399353





Most Viewed Articles
Most Accessed Articles

  • Determination of the optimum filter for 99mTc SPECT breast imaging using a wire mesh collimator
    Xianling Dong, M I Saripan, R Mahmud, S Mashohor, Aihui Wang
    Pak J Nucl Med. 2017; 7(1): 9-15
    » Abstract » doi: 10.24911/PJNMed.7.2

  • Behaviour of wedges for different field sizes and depths
    Sajjad Ahmed Memon, Naeem Ahmed Laghari, Fayaz Hussain Mangi
    Pak J Nucl Med. 2017; 7(1): 20-27
    » Abstract » doi: 10.24911/PJNMed.7.4

  • Pre-operative cardiac risk stratification for noncardiac surgery in cancer patients using myocardial perfusion scintigraphy
    Iqbal Munir, Amrah Javaid, Khalid Nawaz, Mohammed Hathaf Al-Rowaily, Muaadh Abdualrehman Al-Asbahi
    Pak J Nucl Med. 2017; 7(1): 28-33
    » Abstract » doi: 10.24911/PJNMed.7.5

  • Clinical characteristics and long-term outcome of patients with differentiated carcinoma of thyroid with bone metastases: a retrospective study
    Sadaf Tufail Butt, Shazia Fatima, Noreen Marwat, Kahkashan Mir, Ayesha Ammar, Mohammad Faheem
    Pak J Nucl Med. 2017; 7(1): 34-37
    » Abstract » doi: 10.24911/PJNMed.7.6

  • A brief review of targetted radionuclide therapies
    Mohammed Hathaf Al-Rowaily, Daniele Dondi, MarcoChinol, Iqbal Munir, Muaadh Abdualrehman Alasbahi
    Pak J Nucl Med. 2017; 7(1): 4-8
    » Abstract » doi: 10.24911/PJNMed.7.1

  • Most Downloaded
    Top Downloaded Articles

  • Behaviour of wedges for different field sizes and depths
    Sajjad Ahmed Memon, Naeem Ahmed Laghari, Fayaz Hussain Mangi
    Pak J Nucl Med. 2017; 7(1): 20-27
    » Abstract » doi: 10.24911/PJNMed.7.4

  • Determination of the optimum filter for 99mTc SPECT breast imaging using a wire mesh collimator
    Xianling Dong, M I Saripan, R Mahmud, S Mashohor, Aihui Wang
    Pak J Nucl Med. 2017; 7(1): 9-15
    » Abstract » doi: 10.24911/PJNMed.7.2

  • Characterization of SIEMENS Symbia T SPECT camera in Monte Carlo simulation environment
    Xianling Dong, Mahmud Iqbal Saripan, Rozi Mahmud, Syamsiah Mashohor, Aihui Wang,
    Pak J Nucl Med. 2018; 8(1): 18-26
    » Abstract » doi: 10.24911/PJNMed.175-1540569779

  • A historic review of the discovery of the medical uses of radioiodine
    Barbara Hertz, Pushan Bharadwaj, Bennett Greenspan
    Pak J Nucl Med. 2020; 10(1): 60-63
    » Abstract » doi: 10.24911/PJNMed.175-1582813482

  • A brief review of targetted radionuclide therapies
    Mohammed Hathaf Al-Rowaily, Daniele Dondi, MarcoChinol, Iqbal Munir, Muaadh Abdualrehman Alasbahi
    Pak J Nucl Med. 2017; 7(1): 4-8
    » Abstract » doi: 10.24911/PJNMed.7.1

  • Most Cited Articles
    Most Cited Articles